Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Net Sales
230.12
176.59
136.89
Other Operating Income
0.00
0.00
0.00
Total Operating income
230.12
176.59
136.89
Raw Material Cost
15.46
11.08
13.88
Purchase of Finished goods
94.98
72.42
54.94
(Increase) / Decrease In Stocks
-2.82
-2.64
-4.10
Employee Cost
38.86
35.42
25.49
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
42.31
33.93
37.31
Total Expenditure (Excl Depreciation)
188.79
150.20
127.51
Operating Profit (PBDIT) excl Other Income
41.33
26.39
9.38
Other Income
2.05
1.22
0.14
Operating Profit (PBDIT)
43.38
27.61
9.52
Interest
4.58
2.75
2.42
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
38.80
24.86
7.10
Depreciation
6.74
3.40
2.09
Profit Before Tax
32.07
21.46
5.01
Tax
8.55
5.10
1.42
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
23.52
16.36
3.59
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
23.52
16.36
3.59
Share in Profit of Associates
0.00
0.00
-0.22
Minority Interest
-1.34
-0.08
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
22.17
16.28
3.37
Equity Capital
24.45
20.00
20.00
Face Value
10.0
10.0
10.0
Reserves
98.15
21.16
7.30
Earnings per share (EPS)
9.07
8.14
1.69
Diluted Earnings per share
10.78
8.14
1.68
Operating Profit Margin (Excl OI)
17.96%
14.94%
6.85%
Gross Profit Margin
16.86%
14.08%
5.19%
PAT Margin
10.22%
9.26%
2.62%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 30.31% vs 29.00% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 36.18% vs 383.09% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 56.61% vs 181.34% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 66.55% vs 13.64% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Chandan Healthca With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
230.12
337.42
-107.30
-31.80%
Other Operating Income
0.00
0.00
0.00
Total Operating income
230.12
337.42
-107.30
-31.80%
Raw Material Cost
15.46
87.38
-71.92
-82.31%
Purchase of Finished goods
94.98
0.00
94.98
(Increase) / Decrease In Stocks
-2.82
0.00
-2.82
Employee Cost
38.86
53.78
-14.92
-27.74%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
42.31
122.42
-80.11
-65.44%
Total Expenditure (Excl Depreciation)
188.79
263.58
-74.79
-28.37%
Operating Profit (PBDIT) excl Other Income
41.33
73.84
-32.51
-44.03%
Other Income
2.05
4.99
-2.94
-58.92%
Operating Profit (PBDIT)
43.38
78.83
-35.45
-44.97%
Interest
4.58
11.15
-6.57
-58.92%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
38.80
67.68
-28.88
-42.67%
Depreciation
6.74
13.59
-6.85
-50.40%
Profit Before Tax
32.07
54.08
-22.01
-40.70%
Tax
8.55
12.42
-3.87
-31.16%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
23.52
41.66
-18.14
-43.54%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
23.52
41.66
-18.14
-43.54%
Share in Profit of Associates
0.00
0.04
-0.04
-100.00%
Minority Interest
-1.34
0.00
-1.34
Other related items
0.00
0.00
0.00
Consolidated Net Profit
22.17
41.70
-19.53
-46.83%
Equity Capital
24.45
79.90
-55.45
-69.40%
Face Value
10.00
10.00
0.00
Reserves
98.15
78.28
19.87
25.38%
Earnings per share (EPS)
9.07
5.22
3.85
73.75%
Diluted Earnings per share
10.78
5.21
5.57
106.91%
Operating Profit Margin (Excl OI)
17.96%
21.88%
0.00
-3.92%
Gross Profit Margin
16.86%
20.06%
0.00
-3.20%
PAT Margin
10.22%
12.35%
0.00
-2.13%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 230.12 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 30.31% vs 29.00% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 22.17 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 36.18% vs 383.09% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 41.33 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 56.61% vs 181.34% in Mar 2024
Annual - Interest
Interest 4.58 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 66.55% vs 13.64% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.96%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
